BREPHAR
Timeline
30 events since 2005Board
Capital
Filings
Financial
Address
20062008201020122014201620182020202220242026
2024
Annual accounts 2023 filed PDFfull format · 7 days before the deadline
Merger: absorbed by MULTIPHARMAMULTIPHARMA holds all the shares · General meeting of 13-06-20244 points ▸
- General meeting of 13-06-2024
- MULTIPHARMA holds all the shares
- The operation takes effect in the accounts on 01-01-2024
- Power of attorney granted to
- The deed holds 5 more points.
Powers of attorney granted to , and 5 othersBoard meeting of 20-02-20249 points ▸
- Board meeting of 20-02-2024
- Power of attorney granted to (director)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to
Merger proposal: to be absorbed by MULTIPHARMA2 points ▸
- Merger by absorption
- The operation takes effect in the accounts on 01-01-2024
- The deed holds 7 more points.
Registered office moved from Geraardsbergen to AnderlechtThe registered office moved from Vredestraat 6, 9500 Geraardsbergen to Marie Curiesquare 30, 1070 Anderlecht · General meeting of 16-10-20233 points ▸
- General meeting of 16-10-2023
- The registered office moved to Marie Curiesquare 30, 1070 Anderlecht
- Article 2 of the articles of association amended
2023
1 director appointed, 1 statutory auditor appointed, 2 resignations and resign · and (statutory auditor) appointed · acts as permanent representative · General meeting of 02-10-202314 points ▸
- General meeting of 02-10-2023
- resigns as director
- resigns as director
- appointed as director
- appointed as statutory auditor
- acts as permanent representative
- Board meeting of 02-10-2023
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
(director) and (director) appointedLegal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 20-09-20235 points ▸
- General meeting of 20-09-2023
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- appointed as director, not named in the articles
- appointed as director, not named in the articles
- The registered office is at Vredestraat 6, 9500 Geraardsbergen
- The deed holds 3 more points.
Annual accounts 2022 filed PDFabbreviated format · 10 days late
2022
Annual accounts 2021 filed PDFmicro format · 26 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 28 days late
2020
Annual accounts 2019 filed PDFmicro format · 29 days late
2019
Annual accounts 2018 filed PDFabbreviated format · 29 days late
2018
Annual accounts 2017 filed PDFabbreviated format · 21 days late
2017
Annual accounts 2016 filed PDFabbreviated format · 7 days before the deadline
2016
Back to profit net €23,311 The net result is €23,311, after one loss-making year.
Annual accounts 2015 filed PDFabbreviated format · 31 days late
2015
Weakest financial year net -€11,632 The net result drops to -€11,632, the lowest from 2006 to 2023.
Annual accounts 2014 filed PDFabbreviated format · 19 days late
2014
Annual accounts 2013 filed PDFabbreviated format · 16 days late
2013
Annual accounts 2012 filed PDFabbreviated format · 27 days late
2012
Annual accounts 2011 filed PDFabbreviated format · 29 days late
2011
Annual accounts 2010 filed PDFabbreviated format · 17 days before the deadline
2010
Equity above €200,000 equity €233,111 ▲19.6% With a profit in every financial year since 2006, equity grows to €233,111.
Annual accounts 2009 filed PDFabbreviated format · 15 days before the deadline
2009
Annual accounts 2008 filed PDFabbreviated format · 14 days before the deadline
2008
Equity above €150,000 equity €161,150 ▲28.6% With a profit in every financial year since 2006, equity grows to €161,150.
Annual accounts 2007 filed PDFabbreviated format · 6 days before the deadline
2007
Equity above €100,000 equity €125,312 ▲68% With a profit in every financial year since 2006, equity grows to €125,312.
Annual accounts 2006 filed PDFabbreviated format · on the deadline day
2005
Incorporation PDF10 publications in the Belgian Official Gazette, the last on 11-07-2024
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
The registered office was moved to Anderlecht in 2024.1 The board currently has 2 members.2 In 2024 BREPHAR was absorbed by merger into MULTIPHARMA.3